Oncolys BioPharma, Inc. had a revenue of 0.00 in the quarter ending Mar 31, 2024, with ―. This bring the company's revenue in the last twelve months to 28.04M, Increased -55.52%. In the fiscal year ending Dec 31, 2023, Oncolys BioPharma, Inc. had annual revenue of 63.04M with -93.54% growth.